ArticleScientific reports2022
Synergetic effect of green synthesized reduced graphene oxide and nano-zero valent iron composite for the removal of doxycycline antibiotic from water.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Sequential removal of cyanide and phenol using zerovalent iron andRSC advances · 2026Article
- Comparative Structure and Arsenate Removal Performance of Chemically Synthesized andACS omega · 2026Article
- Review
- Eco-friendly synthesis of nZVI for water remediation: latest developments and environmental applications.RSC advances · 2026Review
- Sorbitol-modified graphene oxide-iron oxide nanocomposite for efficient doxycycline removal: mechanistic and kinetic insights.RSC advances · 2026Article
- Graphitic Carbon Nitride and Nickel-Doped Graphitic Carbon Nitride for Doxycycline Removal: Adsorption Efficiency and Mechanistic Insights.Langmuir : the ACS journal of surfaces and colloids · 2025Article
- Green synthesis of magnetic bio-Graphene nanohybrid for the immobilization of hydrolytic enzymes towards sustainable bioconversion of cellulose.RSC advances · 2025Article
- Simplistic synthesis of L-Serine-ZnS composites with distinct morphological nature, enhanced thermal stability and superior photocatalytic enactment for ciprofloxacin removal.Scientific reports · 2025Article
- A Rapid and Complete Photodegradation of Doxycycline Using rGO@CuO Nanocomposite Under Visible and Direct Sunlight: Mechanistic Insights and Real-Time Applicability.Nanomaterials (Basel, Switzerland) · 2025Article
- Zero-valent Iron Nanoparticles: Biogenic Synthesis and their Medical Applications; Existing Challenges and Future Prospects.Current pharmaceutical biotechnology · 2024Review
- Photocatalytic degradation of tetracycline antibiotics by RGO-CdTe composite with enhanced apparent quantum efficiency.Scientific reports · 2023Article
- Dynamics of reduced graphene oxide: synthesis and structural models.RSC advances · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, the synthesis of an rGO/nZVI composite was achieved for the first time using a simple and green procedure via Atriplex halimus leaves extract as a reducing and stabilizing agent to uphold the green chemistry principles such as less hazardous chemical synthesis. Several tools have been used to confirm the successful synthesis of the composite such as SEM, EDX, XPS, XRD, FTIR, and zeta potential which indicated the successful fabrication of the composite. The novel composite was compared with pristine nZVI for the removal aptitude of a doxycycline antibiotic with different initial concentrations to study the synergistic effect between rGO and nZVI. The adsorptive removal of bare nZVI was 90% using the removal conditions of 25 mg L
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.